EJNMMI Research

Article	Citations
Nanobody: a promising toolkit for molecular imaging and disease therapy	93
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review	38
Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis	35
A three-stage, deep learning, ensemble approach for prognosis in patients with Parkinson’s disease	32
Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics	28
Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics	27
External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients	25
Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[18F]FDG PET	24
The pons as reference region for intensity normalization in semi-quantitative analysis of brain 18FDG PET: application to metabolic changes related to ageing in conventional and digital control databa	23
Preliminary study of AI-assisted diagnosis using FDG-PET/CT for axillary lymph node metastasis in patients with breast cancer	23
CERMEP-IDB-MRXFDG: a database of 37 normal adult human brain [18F]FDG PET, T1 and FLAIR MRI, and CT images available for research	22
Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients	22
First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer	21
Imaging modalities for diagnosis and monitoring of cancer cachexia	21
The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer	20
The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0	20
Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer	20
Automated liver lesion detection in 68Ga DOTATATE PET/CT using a deep fully convolutional neural network	19
Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer	19
Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study	18
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET	18
First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor	17
There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography	17
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients	17
Detection of the sentinel lymph node with hybrid tracer (ICG-[99mTc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study	17

Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET	17
Disease activity and response to therapy monitored by [18F]FDG PET/CT using volume-based indices in IgG4-related disease	17
Assessment of early metabolic progression in melanoma patients under immunotherapy: an 18F-FDG PET/CT study	17
PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy	17
Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0	16
Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer	16
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer	16
L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas	16
The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)	16
Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT	15
Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation	15
Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods	15
99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle	15
Sapap3 deletion causes dynamic synaptic density abnormalities: a longitudinal [11C]UCB-J PET study in a model of obsessive–compulsive disorder-like behaviour	15
An update on the use of image-derived input functions for human PET studies: new hopes or old illusions?	15
Detection and therapy of neuroblastoma minimal residual disease using [64/67Cu]Cu-SARTATE in a preclinical model of hepatic metastases	15
Imaging angiogenesis in atherosclerosis in large arteries with 68Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease	15
[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis	14
18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy	14
Evaluation of camera-based freehand SPECT in preoperative sentinel lymph node mapping for melanoma patients	14
Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis	14
Evaluation of image quality with four positron emitters and three preclinical PET/CT systems	13
[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma	13
A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms	13
Predicting PD-L1 expression status in patients with non-small cell lung cancer using [18F]FDG PET/CT radiomics	12
FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET	12
Lung shunt fraction calculation using 99mTc-MAA SPECT/CT imaging for 90Y microsphere selective internal radiation therapy of liver tumors	12
Risk factors for nonvisualization of the sentinel lymph node on lymphoscintigraphy in breast cancer patients	12
A retrospective analysis of the diagnostic performance of 11C-choline PET/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant imaging in primary hyperparathyroid	12
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy	12
Evaluation of [68Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision	12
Convolutional neural networks for detection of transthyretin amyloidosis in 2D scintigraphy images	12
Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation	12
Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging	11
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy	11
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007	11
Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization	11
[68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study	11
A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma	10
The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma	10
Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy	10
Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients	10
Magnetic nanoparticles in theranostics of malignant melanoma	10
Clinical feasibility and impact of data-driven respiratory motion compensation studied in 200 whole-body 18F-FDG PET/CT scans	10
Prospective data-driven respiratory gating of [68Ga]Ga-DOTATOC PET/CT	10
In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201	10
The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis	10
Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and revi	10
Autoradiographical assessment of inflammation-targeting radioligands for atherosclerosis imaging: potential for plaque phenotype identification	10
Conscious rat PET imaging with soft immobilization for quantitation of brain functions: comprehensive assessment of anesthesia effects on cerebral blood flow and metabolism	10

In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease	9
A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240	9
PET imaging of an optimized anti-PD-L1 probe 68Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates	9
Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy	9
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and clinically realistic simulations	9
A dedicated paediatric [18F]FDG PET/CT dosage regimen	9
Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patients	9
Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer	9
Automated and robust organ segmentation for 3D-based internal dose calculation	9
Intraoperative [18F]FDG flexible autoradiography for tumour margin assessment in breast-conserving surgery: a first-in-human multicentre feasibility study	9
The metabolic parameters based on volume in PET/CT are associated with clinicopathological N stage of colorectal cancer and can predict prognosis	9
Direct reconstruction for simultaneous dual-tracer PET imaging based on multi-task learning	9
Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging	9
Sex correction improves the accuracy of clinical dopamine transporter imaging	9
Feasibility of a drop-in γ-probe for radioguided sentinel lymph detection in early-stage cervical cancer	9
Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors	8
Dose escalation biodistribution, positron emission tomography/computed tomography imaging and dosimetry of a highly specific radionuclide-labeled non-blocking nanobody	8
Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation	8
Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT	8
18F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography	8
Predictive value of 99mTc-MAA-based dosimetry in personalized 90Y-SIRT planning for liver malignancies	8
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?	8
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer	8
Post-reconstruction enhancement of [18F]FDG PET images with a convolutional neural network	8
Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example	8
Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging	8
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225	8
CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett’s esophagus	8
Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body 68 Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer afte	8
Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice	7
Whole-body biodistribution and radiation dosimetry of [18F]PR04.MZ: a new PET radiotracer for clinical management of patients with movement disorders	7
Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness	7
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease	7
Larger 18F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors	7
Impact of contouring methods on pre-treatment and post-treatment dosimetry for the prediction of tumor control and survival in HCC patients treated with selective internal radiation therapy	7
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides	7
Impact of cerebral blood flow and amyloid load on SUVR bias	7
Assessing the impact of different penalty factors of the Bayesian reconstruction algorithm Q.Clear on in vivo low count kinetic analysis of [11C]PHNO brain PET-MR studies	7
Semi-quantitative measurements of chemokine receptor 4-targeted 68Ga-pentixafor PET/CT in response assessment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma	7
Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC	7
Current status of contemporary diagnostic radiotracers in the management of breast cancer: first steps toward theranostic applications	7
Rationale for MYC imaging and targeting in pancreatic cancer	7
Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine	7
Clinical impact of digital and conventional PET control databases for semi-quantitative analysis of brain 18F-FDG digital PET scans	7
Engineering a modular 44Ti/44Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry	7
[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism	7
Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A	7
Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on 18F-FDG PET/CT	7
Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study	7
PET-CT imaging of pulmonary inflammation using [68Ga]Ga-DOTA-TATE	7
A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors	7
In vivo vesicular acetylcholine transporter density in human peripheral organs: an [18F]FEOBV PET/CT study	7
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools	7
The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)	6
Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of 18F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag	6
Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules	6
The joint use of 99mTc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning	6
Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study	6
Vessel-by-vessel analysis of lower extremity 18F-NaF PET/CT imaging quantifies diabetes- and chronic kidney disease-induced active microcalcification in patients with peripheral arterial disease	6
Peptide-based PET imaging agent of tumor TIGIT expression	6
Validation and test–retest repeatability performance of parametric methods for [11C]UCB-J PET	6
GMP-compliant fully automated radiosynthesis of [18F]FEPPA for PET/MRI imaging of regional brain TSPO expression	6
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma	6
Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction	6
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients	6
EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases	6
The pharmacokinetics of [18F]UCB-H revisited in the healthy non-human primate brain	6
Specificity of translocator protein-targeted positron emission tomography in inflammatory joint disease	6
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers	6
Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer	6
RETRACTED ARTICLE: Inter- and intraobserver agreement of the quantitative assessment of [99mTc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer	6
Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model	6
Intraoperative visualization of nerves using a myelin protein-zero specific fluorescent tracer	6
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer	6
Competitive blocking of salivary gland [18F]DCFPyL uptake via localized, retrograde ductal injection of non-radioactive DCFPyL: a preclinical study	6
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer	6
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer	6
Amyloid PET quantification using low-dose CT-guided anatomic standardization	5
Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small molecules	5
Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma	5

Sub-minute acquisition with deep learning-based image filter in the diagnosis of colorectal cancers using total-body 18F-FDG PET/CT	5
Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence	5
The association of DAT gene methylation with striatal DAT availability in healthy subjects	5
Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy	5
Can the function of the tubarial glands be evaluated using [99mTc]pertechnetate SPECT/CT, [18F]FDG PET/CT, and [11C]methionine PET/CT?	5
Phantom and clinical evaluation of the effect of a new Bayesian penalized likelihood reconstruction algorithm (HYPER Iterative) on 68Ga-DOTA-NOC PET/CT image quality	5
Differences in [18F]FDG uptake in BAT of UCP1 −/− and UCP1 +/+ during adrenergic stimulation of non-shivering thermogenesis	5
KRAS mutation effects on the 2-[18F]FDG PET uptake of colorectal adenocarcinoma metastases in the liver	5
Multiple-pinhole collimators improve intra- and between-rater agreement and the certainty of the visual interpretation in dopamine transporter SPECT	5
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study	5
Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model	5
Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma	5
Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB1	5
Relevance of 18F-DOPA visual and semi-quantitative PET metrics for the diagnostic of Parkinson disease in clinical practice: a machine learning-based inference study	5
Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies	5
Accuracy comparison of various quantitative [99mTc]Tc-DPD SPECT/CT reconstruction techniques in patients with symptomatic hip and knee joint prostheses	5
In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET	5
Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter	5
Convolutional neural network-based automatic heart segmentation and quantitation in 123I-metaiodobenzylguanidine SPECT imaging	5
Plasma radio-metabolite analysis of PET tracers for dynamic PET imaging: TLC and autoradiography	5
Comparison of [18F] NaF PET/CT dynamic analysis methods and a static analysis method including derivation of a semi-population input function for site-specific measurements of bone formation in a popu	4
The potential application of MR-derived ADCmin values from 68Ga-DOTATATE and 18F-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors	4
Correlation of in vivo imaging to morphomolecular pathology in translational research: challenge accepted	4
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology	4
Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology	4
Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex	4
Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma	4
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis	4
Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer	4
Simultaneous 18F-FDG PET/MR metabolic and structural changes in visual snow syndrome and diagnostic use	4
Quantitation of cancer treatment response by 2-[18F]FDG PET/CT: multi-center assessment of measurement variability using AUTO-PERCIST™	4
TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity	4
Application of the PET ligand [11C]ORM-13070 to examine receptor occupancy by the α2C-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain	4
Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PET	4
N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard	4
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients	4
[18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice	4
Development of a 64Cu-labeled CD4+ T cell targeting PET tracer: evaluation of CD4 specificity and its potential use in collagen-induced arthritis	4
Cost-effectiveness of 82-Rubidium PET myocardial perfusion imaging for the diagnosis of myocardial ischemia depending on the prevalence of coronary artery disease	4
Increased [18F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors	4
Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome	4
Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype	4
Alzheimer’s disease pattern derived from relative cerebral flow as an alternative for the metabolic pattern using SSM/PCA	4
Clinical utility of 18F-FDG PET/CT imaging in patients with pulmonary artery sarcoma	3
Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder	3
Evaluation of intracellular processes in quinolinic acid-induced brain damage by imaging reactive oxygen species generation and mitochondrial complex I activity	3
Alteration of neuroinflammation detected by 18F-GE180 PET imaging in place-conditioned rats with morphine withdrawal	3
Repeatability of [15O]H2O PET imaging for lower extremity skeletal muscle perfusion: a test–retest study	3
The impact of specific pulmonary arterial hypertension therapy on cardiac fluorodeoxyglucose distribution in PET/MRI hybrid imaging–follow-up study	3
An abbreviated therapy-dosimetric equation for the companion diagnostic/therapeutic [64/67Cu]Cu-SARTATE	3
Respiratory motion correction in F-18-FDG PET/CT impacts lymph node assessment in lung cancer patients	3
Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [18F]DCFPyL-PET: comparison to [18F]fluorocholine-PET	3
18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery	3
Prognostic value of baseline total metabolic tumour volume of 18F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma	3
Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment	3
Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer	3
[18F]Fluoride uptake in various bone types and soft tissues in rat	3
Effect of steroid treatment on the diagnostic yield of baseline 18f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma	3
Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3	3
Comparison of metabolic and functional parameters using cardiac 18F-FDG-PET in early to mid-adulthood male and female mice	3
The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2	3
A guideline proposal for mice preparation and care in 18F-FDG PET imaging	3
Diagnostic models for fever of unknown origin based on 18F-FDG PET/CT: a prospective study in China	3
Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells	3
Comparison of nuclear imaging techniques and volumetric imaging for the prediction of postoperative mortality and liver failure in patients undergoing localized liver-directed treatments: a systematic	3
Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL	3
[123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study	3
Correlation of [18F]florbetaben textural features and age of onset of Alzheimer’s disease: a principal components analysis approach	3
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough	3
Region- and voxel-based quantification in human brain of [18F]LSN3316612, a radioligand for O-GlcNAcase	3
Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism	3
Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA	3
Metabolic phenotyping of hand automatisms in mesial temporal lobe epilepsy	3
The effect of eating on the uptake of PSMA ligands in the salivary glands	3
Feasibility of equivalent performance of 3D TOF [18F]-FDG PET/CT with reduced acquisition time using clinical and semiquantitative parameters	3
Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism	3
Evaluation of [68 Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria	3